Insuman implantable ( ) ( 400IU/mL ) ( Sanofi-Aventis Deutschland GmbH , Frankfurt am Main , Germany ) , a recombinant human insulin , has been developed as a replacement for Insuplant ( ) ( Aventis Pharma , Frankfurt am Main , Germany ) , a semisynthetic insulin , the only one used so far .